Mcguire Capital Advisors »

Enlivex Therapeutics shares owned by Mcguire Capital Advisors

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Mcguire Capital Advisors from 13F filings

Historical chart of Mcguire Capital Advisors investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Mcguire Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Mcguire Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8k 2.5k 0.70

More positions owned by Mcguire Capital Advisors

NVIDIA Corporation (NVDA)
Tidal Trust Ii Yieldmax Nvda (NVDY)
Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Exxon Mobil Corporation (XOM)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Oneok (OKE)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Caterpillar (CAT)

View all positions for Mcguire Capital Advisors

Top funds holding Enlivex Therapeutics

Renaissance Technologies
Hrt Financial
Jane Street
Citadel Advisors
XTX Topco
Invesco
Virtu Financial
UBS Group
Prosperity Consulting Group
Neuberger Berman Group
Two Sigma Investments
SkyView Investment Advisors
Wells Fargo & Company
Simplex Trading
Mcguire Capital Advisors

View all funds holding Enlivex Therapeutics